Xiaojiong Jia

Xiaojiong Jia

Auto-generated profile, based on publicly available information

Xiaojiong Jia

Department of Laboratory Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Cancer Letters
Verified
Journal Article
Closed access
QYQiu-Xia Yang
Qiu-Xia Yang
SZShan Zhong
Shan Zhong
LHLin He
Lin He
XJXiao-Jiong Jia
Xiao-Jiong Jia
HTHua Tang
Hua Tang
JCJuan Chen
Juan Chen

20 July 2018 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
XJXiaojiong Jia
Xiaojiong Jia
CLCongya Li
Congya Li
JCJu Cao
Ju Cao
XWXianan Wu
Xianan Wu
LZLiping Zhang
Liping Zhang

1 September 2017 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
JYJinrong Yan
Jinrong Yan
SPShuli Pu
Shuli Pu
XJXiaojiong Jia
Xiaojiong Jia
XXXiuyu Xu
Xiuyu Xu
SYShuangshuang Yang
Shuangshuang Yang
LZLiping Zhang
Liping Zhang
Jinrong Yan, M.D., Shuli Pu, M.D., Xiaojiong Jia, M.D., Xiuyu Xu, M.D., Shuangshuang Yang, M.D., Jing Shi, M.D., Shan Sun, M.D., and Liping Zhang, M.D.. Ann Lab Med 2017;37:398-407. https://doi.org/10.3343/alm.2017.37.5.398

1 March 2018 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
JHJianchun He
Jianchun He
XJXiaojiong Jia
Xiaojiong Jia
SYShuangshuang Yang
Shuangshuang Yang
XXXiuyu Xu
Xiuyu Xu
KSKunling Sun
Kunling Sun
LZLiping Zhang
Liping Zhang

6 March 2020 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
HZHua Zou
Hua Zou
XJXiaojiong Jia
Xiaojiong Jia
HLHang Liu
Hang Liu
SLShuang Li
Shuang Li
XWXianan Wu
Xianan Wu
SHShifeng Huang
Shifeng Huang
The newly emerging NDM-5 confers increased antibiotic resistance and attracts extensive global attention, but the prevalence, dissemination mechanism, and clinical significance of NDM-5 among clinical Escherichia coli (E. coli) infections have not been thoroughly characterized to date. In the present study, 109 unique carbapenem-resistant E. coli (CR-EC) isolates were collected in Southwest China, from 2013 to 2017, among which 41 (37.61%) CR-EC isolates were identified as NDM-5-producers, with most isolates carrying the IncF-type plasmids. Molecular epidemiological studies revealed ST167 being the most common sequence type (ST). Moreover, we described the first report of a clinical CR-EC isolate co-harboring blaKPC–2 and blaNDM–5, which showed a higher level of resistance to carbapenems. In addition, blaNDM–5 plasmid transformation and conjugation indicated that blaNDM–5 itself did confer resistance to carbapenems. Complete sequencing of the blaNDM–5-harboring IncF plasmid revealed highly conserved regions (bleMBL-trpF-tat) and some transposons around blaNDM–5. Our findings revealed a new potential threat of NDM-5-postive CR-EC in mainland China and emphasized an urgent need to control their further spread.

1 August 2018 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
SLShuang Li
Shuang Li
XJXiaojiong Jia
Xiaojiong Jia
CLCongya Li
Congya Li
HZHua Zou
Hua Zou
HLHang Liu
Hang Liu
LZLiping Zhang
Liping Zhang
Purpose: Pseudomonas aeruginosa is recognized as a major cause of severe and potentially life-threatening infection. However, P. aeruginosa isolates with the phenotype of being carbapenem resistant and cephalosporin susceptible (Carb-R/Ceph-S) have not been thoroughly characterized to date. The aim of this study was to assess the mechanisms, risk factors, and clinical impact of Carb-R/Ceph-S P. aeruginosa bacteremia on mortality. Patients and methods: We conducted a retrospective case–case–control study of the risk factors and clinical outcomes of hospitalized patients with Carb-R/Ceph-S P. aeruginosa bacteremia from 2011 to 2017 in Chongqing, China. Case patients infected with Carb-R/Ceph-S P. aeruginosa, carbapenem-susceptible and cephalosporin-susceptible (Carb-S/Ceph-S) P. aeruginosa, and controls with no P. aeruginosa bacteremia were compared at a ratio of 1:1:2. Real-time reverse transcription polymerase chain reaction was performed to assess resistance mechanisms. A multivariate logistic regression model was performed to investigate several potential predictors for mortality. Results: We collected 63 Carb-R/Ceph-S P. aeruginosa isolates during the study period. None of these isolates possessed carbapenemase or extended-spectrum β-lactamase-encoding genes. The overall 30-day mortality rate was 27.0%. Real-time reverse transcription polymerase chain reaction analysis showed that an overexpression of efflux systems and decreased expression of OprD were associated with Carb-R/Ceph-S P. aeruginosa. Multivariate analysis indicated that 30-day readmission, central venous catheters, and exposure to carbapenems were unique independent predictors for acquiring Carb-R/Ceph-S P. aeruginosa bacteremia. Additionally, hematologic malignancy was a peculiar predictor for Carb-S/Ceph-S P. aeruginosa bacteremia. Notably, total parenteral nutrition was the only common factor of both Carb-R/Ceph-S and Carb-S/Ceph-S groups compared to controls. In a multivariate analysis for the outcome, intensive care unit admission and septic shock were identified as the independent predictors for mortality. Conclusion: Our findings can potentially improve the ability of physicians to identify the high-risk patients, and carbapenems were noted to potentially increase the risk of Carb-R/Ceph-S P. aeruginosa. Additionally, cephalosporin should be considered a valuable therapeutic option for such cases of bacteremia.